Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases

@article{Godeau1997DapsoneFC,
  title={Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases},
  author={Bertrand Godeau and Jean Marc Durand and Francoise Roudot-thoraval and A Tennez{\'e} and Eric Oksenhendler and Gilles Kaplanski and Annette Schaeffer and Philippe Bierling},
  journal={British Journal of Haematology},
  year={1997},
  volume={97}
}
Sixty‐six adults with chronic autoimmune thrombocytopenic purpura AITP and platelet count <50 ×109 l were treated with dapsone (75–100 mg orally). A response was observed in 33 patients. The median duration of treatment required to obtain a response was 21 d (range 8–90). The median maximal platelet count on treatment was 130 × 109 l (range 71–355). Dapsone was continued in 20/33 responders for a median of 12.5 months (range 1–48) and the response persisted in 19. Treatment was intentionally… Expand
Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults – a report on 90 patients
TLDR
It is demonstrated that dapsone is an effective, inexpensive and well‐tolerated treatment for chronic ITP, in both children and adults and could be considered for patients who fail steroid therapy. Expand
Dapsone Therapy for Children With Immune Thrombocytopenic Purpura
TLDR
Dapsone has been shown to be effective in treating adults with immune thrombocytopenic purpura (ITP), and children receiving dapsone should be monitored for methemoglobinemia. Expand
Dapsone for immune thrombocytopenic purpura in children and adults
TLDR
Dapsone is a safe and cheap second-line therapy for ITP with a response rate of about 50% (majority being CR), and a response to daps one is slow, sustained, and relapses are uncommon on therapy. Expand
Treatment of immune thrombocytopenic purpura in adults.
TLDR
The role of newer therapies with diverse mechanisms of action, such as rituximab, anti-D, and thrombopoietin (TPO)-like agents, will be highlighted and may offer a more tolerable side effect profile and improved clinical benefit compared to existing drugs. Expand
Management of adult idiopathic thrombocytopenic purpura.
TLDR
Criteria for treatment, the roles of splenectomy and other treatment options along with their side effects, and the management of ITP during pregnancy are discussed. Expand
Dapsone therapy for refractory immune thrombocytopenia patients: a case series
TLDR
Dapsone is still useful for some patients, but it may be ineffective in heavily pretreated patients with profound thrombocytopenia, and should be considered as a second-line immunosuppressive agent. Expand
Management of immune thrombocytopenic purpura in adults.
TLDR
A logical and structured approach to the clinical management of ITP in adults is described, based on a literature review and personal experience, which aims to add more effective and targeted strategies to the therapeutic armamentarium. Expand
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura.
TLDR
The goal of treatment is not cure of the ITP, but only to achieve a safe platelet count, which is arbitrarily assumed to be greater than 30,000 to 50,000/microL, which seems great only when the risk for major bleeding seems great, and treatment of patients with moderate thrombocytopenia and no clinically important bleeding symptoms should be avoided. Expand
13 Management of Immune Thrombocytopenic Purpura in Adults
MB Agarwal, Shyam A Rathi Abstract: Primary immune thrombocytopenic purpura (ITP) is a heterogenous disease with variable severity and clinical course. It is unpredictable in its response toExpand
Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
TLDR
The recent United States Food and Drug Administration approval of the thrombo‐poietin mimetics, romiplostim and eltrombopag, has provided clinicians with a novel approach for treating chronic refractory ITP by stimulating platelet production. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 12 REFERENCES
Dapsone for autoimmune thrombocytopenic purpura
TLDR
Dapsone is a safe, inexpensive, and effective treatment of autoimmune thrombocytopenia in HIV‐infected adults with AITP and no serious hematological complications were observed. Expand
Dapsone for refractory chronic idiopathic thrombocytopenic purpura
TLDR
In the experience, dapsone provides an inexpensive and well‐tolerated alternative for patients with ITP who had inadequate reponses to conventional therapy. Expand
Pulsed high‐dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases
TLDR
Ten patients who had chronic refractory idiopathic thrombocytopenic purpura with high‐dose dexamethasone (DXM, 40mg/d for 4 sequential days every month) were treated with DXM, and eight patients received at least three cycles of DXM. Expand
DAPSONE FOR IDIOPATHIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA IN ELDERLY PATIENTS
TLDR
Dapsone was used to treat patients with chronic ITP on the basis that the drug might modulate the macrophage behaviour responsible for the platelet lysis, and patients had a significant increase in platelet count, which was classified as complete response (CR), partial response (PR), and no response (NR). Expand
Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin.
TLDR
This study shows that an i.v. IgG infusion regimen of 1 g/ kg body weight could safely replace the classical 2 g/kg body weight dosage, at least in patients who do not have life-threatening thrombocytopenia, and could be an alternative for AITP patients in whom splenectomy is contraindicated. Expand
Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
  • J. Andersen
  • Medicine
  • The New England journal of medicine
  • 1994
TLDR
P pulsed high-dose treatment with dexamethasone may provide a low-cost therapeutic option with minimal side effects in patients with refractory idiopathic thrombocytopenic purpura. Expand
Chronic idiopathic thrombocytopenic purpura.
TLDR
The high rate of increase in self-poisoning in both immigrant groups, but particularly West Indians, presumably reflects the stresses of these communities in adjusting to life in Birmingham. Expand
Autoimmune Thrombocytopenia: Detection of Platelet Autoantibodies with the Suspension Immunofluorescence Test
Summary An immunofluorescence test on paraformaldehyde‐fixed platelets in suspension was used for the detection of antibodies on platelets and in the sera of patients with idiopathic or secondaryExpand
A Simple Immunofluorescence Test for the Detection of Platelet Antibodies
TLDR
By using PFA‐fixed platelets, a simple method for the detection of platelet antibodies, the platelet suspension immunofluorescence test (PSIFT) was developed. Expand
...
1
2
...